# EDGAR Filing Document

**Accession Number:** 0000704440
**File Stem:** 0001161697-26-000042
**Filing Date:** 2026-2
**Character Count:** 23955
**Document Hash:** 74f3df91adad534380615e23e67f28de
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001161697-26-000042.hdr.sgml**: 20260213

**ACCESSION NUMBER**: 0001161697-26-000042

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260213

**DATE AS OF CHANGE**: 20260213

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KORU Medical Systems, Inc.
- **CENTRAL INDEX KEY:** 0000704440
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 133044880
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-34813
- **FILM NUMBER:** 26634178

**BUSINESS ADDRESS:**
- **STREET 1:** 100 CORPORATE DRIVE
- **CITY:** MAHWAH
- **STATE:** NJ
- **ZIP:** 07430
- **BUSINESS PHONE:** 845-469-2042

**MAIL ADDRESS:**
- **STREET 1:** 100 CORPORATE DRIVE
- **CITY:** MAHWAH
- **STATE:** NJ
- **ZIP:** 07430

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** REPRO MED SYSTEMS INC
- **DATE OF NAME CHANGE:** 19920703
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Horton Capital Partners, LLC
- **CENTRAL INDEX KEY:** 0001575443

**ORGANIZATION NAME:**
- **EIN:** 461613207
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 1717 ARCH STREET
- **STREET 2:** 37TH FLOOR
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19103
- **BUSINESS PHONE:** (215) 399-5402

**MAIL ADDRESS:**
- **STREET 1:** 1717 ARCH STREET
- **STREET 2:** 37TH FLOOR
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19103

## Ex-99

**Exhibit 1**

**JOINT FILING AGREEMENT**

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing with the Securities and Exchange Commission on behalf of each of them of Schedule 13D/A, to which this Exhibit 1 is attached (including amendments thereto) with respect to certain shares of common stock of KORU Medical Systems, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement shall be included as an exhibit to such filing.

This Joint Filing Agreement may be executed in counterparts, each of which when so executed shall be deemed to be an original, and all of which together shall be deemed to constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Joint Filing Agreement.

---

| | | |
|:---|:---|:---|
| Dated: February 13, 2026 | **HORTON CAPITAL PARTNERS FUND, LP** | **HORTON CAPITAL PARTNERS FUND, LP** |
|  | **By:** | **Horton Capital Partners, LLC,** |
|  |  | **its General Partner** |
|  | By: | /s/ Joseph M. Manko, Jr. |
|  | Name: | Joseph M. Manko, Jr. |
|  | Title: | Managing Member |

---

---

| | |
|:---|:---|
| **HORTON FREEDOM, LP** | **HORTON FREEDOM, LP** |
| **By:** | **Horton Capital Partners, LLC,** |
|  | **its General Partner** |
| By: | /s/ Joseph M. Manko, Jr. |
| Name: | Joseph M. Manko, Jr. |
| Title: | Managing Member |

---

---

| | |
|:---|:---|
| **HORTON CAPITAL PARTNERS, LLC** | **HORTON CAPITAL PARTNERS, LLC** |
| By: | /s/ Joseph M. Manko, Jr. |
| Name: | Joseph M. Manko, Jr. |
| Title: | Managing Member |

---

---

| | |
|:---|:---|
| **HORTON CAPITAL MANAGEMENT, LLC** | **HORTON CAPITAL MANAGEMENT, LLC** |
| By: | /s/ Joseph M. Manko, Jr. |
| Name: | Joseph M. Manko, Jr. |
| Title: | Managing Member |

---

---

| |
|:---|
| /s/ Joseph M. Manko, Jr. |
| **JOSEPH M. MANKO, JR.** |

---

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 12)**

**KORU Medical Systems, Inc.**

*(Name of Issuer)*

**Common Stock, Par Value $0.01 Per Share**

*(Title of Class of Securities)*

**759910102**

*(CUSIP Number)*

**JOSEPH M. MANKO, JR.**<br>HORTON CAPITAL PARTNERS, LLC<br>1717 Arch Street, Suite 3740<br>Philadelphia PA 19103<br>(215) 399 5402

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**02/13/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **759910102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Horton Capital Partners Fund, LP** | Name of reporting person<br>**Horton Capital Partners Fund, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**5062498.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**5062498.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**5062498.00** | Aggregate amount beneficially owned by each reporting person<br>**5062498.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**10.93%** | Percent of class represented by amount in Row (11)<br>**10.93%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **759910102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Horton Capital Partners, LLC** | Name of reporting person<br>**Horton Capital Partners, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**5062498.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**5062498.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**5062498.00** | Aggregate amount beneficially owned by each reporting person<br>**5062498.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**10.93%** | Percent of class represented by amount in Row (11)<br>**10.93%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

| **CUSIP No.** | **759910102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Horton Capital Management, LLC** | Name of reporting person<br>**Horton Capital Management, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**5062498.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**5062498.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**5062498.00** | Aggregate amount beneficially owned by each reporting person<br>**5062498.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**10.93%** | Percent of class represented by amount in Row (11)<br>**10.93%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **759910102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Joseph M. Manko, Jr.** | Name of reporting person<br>**Joseph M. Manko, Jr.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**782547.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**5062498.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**782547.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**5062498.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**5845045.00** | Aggregate amount beneficially owned by each reporting person<br>**5845045.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**12.62%** | Percent of class represented by amount in Row (11)<br>**12.62%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, Par Value $0.01 Per Share

**(b) Name of Issuer:**
KORU Medical Systems, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
100 Corporate Drive, Mahwah, NJ, 07430

This statement relates to shares of common stock, par value $0.01 per share ("Common Stock"), of Koru Medical Systems, Inc., a Delaware corporation (the "Issuer").  The address of the principal executive offices of the Issuer is 100 Corporate Drive, Mahwah, New Jersey.

Horton Capital Partners Fund, LP, a Delaware limited partnership ("HCPF"), Horton Capital Partners LLC, a Delaware limited liability company ("HCP"), Horton Capital Management, LLC, a Delaware limited liability company ("HCM"), and Joseph M. Manko, Jr. ("Mr. Manko") filed Schedule 13D with the Securities and Exchange Commission (the "SEC") on May 23, 2017, as amended by Amendments Nos. 1 - 11 filed on December 4, 2017, December 21, 2017, March 16, 2018, September 20, 2018, December 21, 2018, January 29, 2020, August 20, 2020, April 6, 2021, February 24, 2023, December 29, 2023, and January 21, 2025 ("Schedule 13D"), to report their beneficial ownership of the shares of Common Stock of the Issuer.  This Amendment No. 12 ("Amendment No. 12") is filed with the SEC to amend and supplement Schedule 13D.

**Item 4. Purpose of Transaction**

The Reporting Persons acquired the shares of Common Stock for investment purposes. The purpose of this Amendment No. 12 is to disclose changes in the beneficial ownership of the shares of Common Stock held by the Reporting Persons including: (i) the issuance of shares of Common Stock to HCPF in consideration for Mr. Manko's service as a director of the Issuer (the "Director Shares"); (ii) that HCPF transferred shares of Common Stock to certain of its limited partners; and (iii) that HCP transferred shares of Common Stock to certain of its members, including Mr. Manko.

On January 10, 2024, Horton Freedom, L.P., ("Horton Freedom") in accordance with its terms, transferred 453,231 shares of Common Stock to certain of its limited partners, representing the remaining pro-rata in-kind distribution in respect of such limited partners' interests in Horton Freedom. As a result, as of January 10, 2024, Horton Freedom held 0 shares of Common Stock.

On February 15, 2024, HCPF, in accordance with its terms, transferred 27,700 shares of Common Stock to a limited partner, representing a pro-rata in-kind distribution in respect of such limited partner's interest in HCPF.

On March 31, 2024, 6,329 Director Shares were issued to HCPF; on June 30, 2024, 5,545 Director Shares were issued to HCPF; on September 30, 2024, 5,454 Director Shares were issued to HCPF; and on December 31, 2024, 3,937 Director Shares were issued to HCPF.

On July 24, 2024, HCPF, in accordance with its terms, transferred 721,781 shares of Common Stock to a limited partner, representing a pro-rata in-kind distribution in respect of such limited partner's interest in HCPF.

On January 21, 2025, HCPF, in accordance with its terms, transferred 1,000,000 shares of Common Stock to certain of its limited partners, including HCP, representing a pro-rata in-kind distribution in respect of such limited partners' interest in HCPF. HCP subsequently transferred 1,000,000 shares of Common Stock received from HCPF to its members, including 351,948 shares of Common Stock to Mr. Manko.

On March 31, 2025, 5,870 Director Shares were issued to HCPF; on June 30, 2025, 4,189 Director Shares were issued to HCPF; on September 30, 2025, 3,916 Director Shares were issued to HCPF; and on December 31, 2025, 2,581 Director Shares were issued to HCPF.

On May 20, 2025, HCPF, in accordance with its terms, transferred 14,317 shares of Common Stock to a limited partner, representing a pro-rata in-kind distribution in respect of such limited partner's interest in HCPF.

On November 26, 2025, HCPF, in accordance with its terms, transferred 41,000 shares of Common Stock to a limited partner, representing a pro-rata in-kind distribution in respect of such limited partner's interest in HCPF.

On February 13, 2026, HCPF, in accordance with its terms, transferred 770,418 shares of Common Stock to certain of its limited partners, including HCP, representing a pro-rata in-kind distribution in respect of such limited partners' interest in HCPF. HCP subsequently transferred 750,000 shares of Common Stock received from HCPF to its members, including 282,347 shares of Common Stock to Mr. Manko.

Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of shares of Common Stock at prices that would make the purchase or sale of such shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of shares of Common Stock on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.

No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of the form of Schedule 13D, except as set forth herein, or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer's financial position and investment strategy, the price levels of the shares of Common Stock of the Issuer, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in additional communications with management and the Board of the Issuer, engaging in discussions with stockholders of the Issuer and others about the Issuer and the Reporting Persons' investment, making proposals to the Issuer concerning changes to the capitalization, ownership structure, board structure (including board composition) or operations of the Issuer, purchasing additional shares of Common Stock, selling some or all of their shares of Common Stock, or changing their intention with respect to any and all matters referred to in Item 4.

Notwithstanding any of the foregoing, the Reporting Persons may at any time modify, change, abandon, or replace, some or all of the foregoing purposes and plans and discussions relating thereto or discontinue or re-continue such modifications, changes, abandonments, or replacements at any time.

**Item 5. Interest in Securities of the Issuer**

**(a)**
See the Reporting Persons section of this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons.

The percentages used herein are calculated based upon 46,322,655 shares of Common Stock issued and outstanding as of November 12, 2025, pursuant to the Quarterly Report on Form 10-Q filed by the Issuer with the SEC on November 12, 2025.

As of the close of business on February 13, 2026:

HCPF owns directly 5,062,498 shares of Common Stock.  HCM maintains discretionary investment and voting authority with respect to 5,062,498 shares of Common Stock held by HCPF.  HCP may be deemed to be the beneficial owner of such shares of Common Stock because, in the event HCM's investment advisory agreement with respect to such shares of Common Stock are terminated, HCP has the right to assume HCM's discretionary investment and voting authority with respect to such shares of Common Stock. HCP is the general partner of HCPF. Mr. Manko owns directly 782,547 shares of Common Stock. Mr. Manko is the managing member of both HCM and HCP and may be deemed to be the beneficial owner of the shares of Common Stock held by HCPF. Each of HCM, HCP, and Mr. Manko disclaims beneficial ownership of the shares of Common Stock held by HCPF.

**(b)**
See the Reporting Persons section of this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

As of the close of business on February 13, 2026:

HCPF owns directly 5,062,498 shares of Common Stock.  HCM maintains discretionary investment and voting authority with respect to 5,062,498 shares of Common Stock held by HCPF.  HCP may be deemed to be the beneficial owner of such shares of Common Stock because, in the event HCM's investment advisory agreement with respect to such shares of Common Stock are terminated, HCP has the right to assume HCM's discretionary investment and voting authority with respect to such shares of Common Stock. HCP is the general partner of HCPF. Mr. Manko owns directly 782,547 shares of Common Stock. Mr. Manko is the managing member of both HCM and HCP and may be deemed to be the beneficial owner of the shares of Common Stock held by HCPF. Each of HCM, HCP, and Mr. Manko disclaims beneficial ownership of the shares of Common Stock held by HCPF.

**(c)**
HCPF transferred 750,000 shares to HCP on February 13, 2026.
HCP received and transferred 750,000 shares to its members on February 13, 2026.
HCM has not entered into any transactions in the securities of the Issuer during the past 60 days.
Mr. Manko received 282,347 shares from HCP on February 13, 2026.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Mr. Manko is a member of the Issuer's Board of Directors.

The Reporting Persons have entered into a Joint Filing Agreement, attached hereto as Exhibit 1, pursuant to which they have agreed to file this Amendment No. 12 jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

The responses to Items 3, 4, and 5 of this Amendment No. 12 are incorporated herein by reference.

Other than as described herein, there are no contracts, arrangements, understandings, or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Horton Capital Partners Fund, LP

**Signature:** /s/ Joseph M. Manko, Jr.

**Name/Title:** Joseph M. Manko, Jr./Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP

**Date:** 02/13/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Horton Capital Partners, LLC

**Signature:** /s/ Joseph M. Manko, Jr.

**Name/Title:** Joseph M. Manko, Jr./Managing Member

**Date:** 02/13/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Horton Capital Management, LLC

**Signature:** /s/ Joseph M. Manko, Jr.

**Name/Title:** Joseph M. Manko, Jr./Managing Member

**Date:** 02/13/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Joseph M. Manko, Jr.

**Signature:** /s/ Joseph M. Manko, Jr.

**Name/Title:** Joseph M. Manko, Jr.

**Date:** 02/13/2026